UniProtKB/SwissProt variant VAR

Variant information

Variant position:

1730

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:

LP/P [Disclaimer]

The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Tyrosine (Y) to Cysteine (C) at position 1730 (Y1730C, p.Tyr1730Cys).

Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:

Change from large size and aromatic (Y) to medium size and polar (C)

The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:

-2

The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page

Variant description:

In FA5D; Seoul 2.

Any additional useful information about the variant.

Other resources:

Links to websites of interest for the variant.

Variant rs118203907 [ dbSNP | Ensembl ]

Sequence information

Variant position:

1730

The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:

2224

The length of the canonical sequence.

Location on the sequence:

WHATERSGPESPGSACRAWA Y YSAVNPEKDIHSGLIGPLLI

The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         WHATERSGPESPGSACRAWAYYSAVNPEKDIHSGLIGPLLI

Mouse                         WHATKRSGPENPGSACRAWAYYSAVNVERDIHSGLIGPLLI

Pig                           WHATERSGPESPGSACRAWAYYSAVNPEKDIHSGLIGPLLI

Bovine                        WHATTRSGPENPGSACRAWAYYSAVNPEKDIHSGLIGPLLI

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	29 – 2224	Coagulation factor V
Chain	1574 – 2224	Coagulation factor V light chain
Domain	1578 – 1907	F5/8 type A 3
Domain	1578 – 1751	Plastocyanin-like 5
Disulfide bond	1725 – 1751

Literature citations

Combinations of 4 mutations (FV R506Q, FV H1299R, FV Y1702C, PT 20210G/A) affecting the prothrombinase complex in a thrombophilic family.
Castoldi E.; Simioni P.; Kalafatis M.; Lunghi B.; Tormene D.; Girelli D.; Girolami A.; Bernardi F.;
Blood 96:1443-1448(2000)
Cited for: VARIANT FA5D CYS-1730; VARIANT THPH2 GLN-534; VARIANT ARG-1327;

Five novel mutations in the gene for human blood coagulation factor V associated with type I factor V deficiency.
van Wijk R.; Nieuwenhuis K.; van den Berg M.; Huizinga E.G.; van der Meijden B.B.; Kraaijenhagen R.J.; van Solinge W.W.;
Blood 98:358-367(2001)
Cited for: VARIANTS THPH2 ARG-613 AND CYS-1730;

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P12259: Variant p.Tyr1730Cys